Clinical trial
The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke…
NCT00196040 · Cierra, Industry · Completed
Key facts
| NCT number | NCT00196040 |
|---|---|
| Title | The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness |
| Official title | Feasibility Study of the PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness |
| Lead sponsor | Cierra, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Foramen Ovale, Patent |
| Intervention type | Device |
| Interventions | PFX Closure System |
| Enrollment | 60 |
| Start date | Oct 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 24, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: